Freya Noble, writing for 9News:
The Therapeutic Goods Administration (TGA) has made an interim decision on whether some psychoactive drugs can be used to treat mental illness in Australia.
The TGA chose not to reschedule MDMA and psilocybin, the active ingredient in magic mushrooms, from a prohibited substance (schedule 9) to a controlled medicine (schedule 8).
A reclassification would not mean the drugs could be taken home with a patient or change any restrictions on recreational use of the substances.
This is obviously a bummer for Mind Medicine Australia and Aussies across the country who could benefit from the therapeutic use of psychedelics, but the organization is already preparing to contest the TGA’s decision. The fight for legal psilocybin and MDMA therapy isn’t over yet.